Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.007 AUD | 0.00% | 0.00% | -12.50% |
Apr. 10 | Patrys Reports 'Positive' Results for Deoxymabs in Autoimmune Vasculitis Treatment | MT |
Feb. 23 | Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 3.33M 2.22M | Sales 2023 | 2.85M 1.9M | Capitalization | 20.57M 13.67M |
---|---|---|---|---|---|
Net income 2022 | -6M -3.99M | Net income 2023 | -7M -4.65M | EV / Sales 2022 | 9.39 x |
Net cash position 2022 | 9.82M 6.53M | Net cash position 2023 | 4.05M 2.69M | EV / Sales 2023 | 5.8 x |
P/E ratio 2022 |
-5.78
x | P/E ratio 2023 |
-2.91
x | Employees | 10 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 69.29% |
1 month | -12.50% | ||
3 months | -22.22% | ||
Current year | -12.50% |
Managers | Title | Age | Since |
---|---|---|---|
James Campbell
CEO | Chief Executive Officer | - | 14-11-11 |
Chief Tech/Sci/R&D Officer | - | 12-05-31 | |
Rebecca Tunstall
PRN | Corporate Officer/Principal | - | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pamela Klein
BRD | Director/Board Member | 63 | 19-09-30 |
James Campbell
CEO | Chief Executive Officer | - | 14-11-11 |
Michael Stork
BRD | Director/Board Member | - | 07-02-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 0.007 | 0.00% | 2 851 |
24-06-05 | 0.007 | -12.50% | 12,479 |
24-06-04 | 0.008 | 0.00% | 575,392 |
24-06-03 | 0.008 | +14.29% | 700,016 |
24-05-31 | 0.007 | 0.00% | 1,899,578 |
Delayed Quote Australian S.E., June 05, 2024 at 08:06 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-12.50% | 9.55M | |
+55.70% | 59.34B | |
+43.00% | 40.24B | |
-5.39% | 39.88B | |
-5.56% | 28.55B | |
+16.46% | 27.26B | |
-20.56% | 19.23B | |
+33.03% | 12.61B | |
+25.85% | 12.28B | |
+2.72% | 12.49B |
- Stock Market
- Equities
- PAB Stock